Researchers at Mount Sinai have developed a novel approach to cancer immunotherapy, injecting immune stimulants directly into a tumor to teach the immune system to destroy it and other tumor cells throughout the body.
The “in situ vaccination” worked so well in patients with advanced-stage lymphoma that it is also undergoing trials in breast and head and neck cancer patients, according to a study published in Nature Medicine in April.
The treatment consists of administering a series of immune stimulants directly into one tumor site. The first stimulant recruits important immune cells called dendritic cells that act like generals of the immune army. The second stimulant activatesthe dendritic cells, which then instruct T cells, the immune system’s soldiers, to kill cancer cells and spare non-cancer cells. This immune army learns to recognize features of the tumor cells so it can seek them out and destroy them throughout the body, essentially turning the tumor into a cancer vaccine factory.
“The in situ vaccine approach has broad implications for multiple types of cancer,” said lead author Joshua Brody, MD, Director of the Lymphoma Immunotherapy Program at The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai. “This method could also increase the success of other immunotherapies such as checkpoint blockade.”
After testing the lymphoma vaccine in the lab, it was tested in 11 patients in a clinical trial. Some patients had full remission from months to years. In lab tests in mice, the vaccine drastically increased the success of checkpoint blockade immunotherapy, the type of immunotherapy responsible for the complete remission of former President Jimmy Carter’s cancer and the focus of the 2018 Nobel Prize in Medicine.
A clinical trial for lymphoma, breast, and head and neck cancer patients opened in March to test the vaccine with checkpoint blockade drugs. Because the combined immune therapy was at least three times more powerful than either checkpoint blockade or the vaccine by themselves, researchers are extremely optimistic about how effective this may be in patients in this new trial. The in situ vaccine is also being tested in the lab in liver and ovarian cancer.
The Latest on: Cancer immunotherapy
[google_news title=”” keyword=”cancer immunotherapy” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Cancer immunotherapy
- Triple Negative Breast Cancer: Expert Consensus on Local Treatment Optionson November 29, 2023 at 3:59 pm
Hong Kong Breast Cancer Foundation Launches "Immunotherapy Drug Financial Assistance Programme" to Benefit Patients in Need After extensive discussions and voting, the expert panel reached a local ...
- Harnessing the Power of the Immune System: Advances in Cancer Immunotherapyon November 27, 2023 at 8:43 am
This article will explore the role of the immune system and immune evasion in cancer and will discuss how the immune system can be exploited therapeutically and the recent advances in cancer ...
- Immunotherapy drug proves promising for deadly small cell lung canceron November 26, 2023 at 5:07 pm
Researchers have published the results of a clinical trial evaluating the efficacy of an immunotherapy drug in treating a particularly aggressive form of lung cancer. Tarlatamab produced promising ...
- The Impact of Immunotherapy on Sleep and Circadian Rhythms in Patients with Canceron November 26, 2023 at 4:01 pm
The University of Texas MD Anderson Cancer Center, Houston, TX, United States Immunotherapy has revolutionized treatments for both early and advanced cancers, and as their role evolves, their impact ...
- Nutrients in Beef and Dairy Promote Cancer Immunotherapyon November 23, 2023 at 1:48 am
A fatty acid present in dairy products, beef, and lamb called trans-vaccenic acid enhances immune cells' capacity to combat cancers.
- Tumor antigens key to improving cancer immunotherapy, study suggestson November 22, 2023 at 7:55 am
Just as the body's immune system can fight off infection, it can be a powerful weapon against cancer. Harnessing and fine-tuning that weapon, however, will require a better understanding of the ...
- Immuno-oncology: the leading companies in cancer immunotherapy revealedon November 14, 2023 at 4:00 pm
Cancer immunotherapy treats cancer by harnessing the body’s own immune system to recognize and attack cancer cells. Unlike traditional cancer treatments, immunotherapy works by boosting the immune ...
- Cancer immunotherapy unleashed: Exploring the role of immune checkpoint inhibitorson November 12, 2023 at 10:50 pm
Cancer immunotherapy recently arose as a highly effective method for cancer treatment. 1 Immunotherapy exploits the body’s immune system for the prevention, management, and eradication of cancer ...
- "Off-the-shelf" cancer immunotherapy inches closer with new mouse studyon November 12, 2023 at 9:44 pm
Immunotherapy is a promising cancer treatment, but it can take too long to administer. In a new study, scientists at UCLA have taken steps towards an “off-the-shelf” therapy that could be mass ...
- Why immunotherapy is emerging as the ‘fourth pillar’ of cancer treatments, experts sayon November 3, 2023 at 2:00 am
For decades, the go-to treatments for cancer have been chemotherapy, radiation and surgery — but a fourth option is showing promising results. Immunotherapy — which some experts are calling ...
via Bing News